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Hypertension in terminal renal failure. Inverse interrelations be-
tween plasma renin activity and exchangeable sodium or blood
volume were found in both normotensive (N = 23) and hyperten-
sive (N = 29)hemodialysis patients (r = 0.47; P K 0.005); however,
mean plasma renin for any given sodium/volume state was at least
two-fold higher in hypertensive than in normotensive hemodialysis
patients or normal subjects (N = 31). In the hemodialysis patients,
blood pressure correlated weakly but significantly with the pro-
ducts of circulating renin and exchangeable sodium (r = 0.37; P <
0.005) or blood volume (r = 0.29; P < 0.05). Multiple regression
analysis including duration of previous hypertension as the second
independent variable increased these correlation coefficients to
0.44 and 0.42, respectively. This suggests that hypertension in end-
stage kidney disease is often associated with resetting of the body
sodium/fluid-renin feedback mechanism, Inappropriately in-
creased plasma renin activity relative to the body sodium/volume
state as well as high blood pressure-induced vascular changes may
play important complementary roles, but it appears evident that
additional mechanisms are also operative in maintaining end-stage
renal hypertension.
Hypertension an cours de l'insuffisance rénale terminale. Des
relations inverses entre l'activitC rénine plasmatique et Ic sodium
échangeable vu le volume sanguin (r > 0,47; P < 0,005) ont
été observées chez les malades en hémodialyse aussi bien normo-
tendus (N = 23) qu'hypertendus (N = 29); l'activité rénine
plasmatique pour une même situation sodium/volume est, cepen-
dant, au moms deux fois plus élevée chez les malades hyper-
tendus que chez les hémodialysés normotendus ou les sujets
normaux (N = 31). Chez les malades en hémodialyse La pression
sanguine est faiblement mais significativement corrélée avec les
produits de La rénine circulante d'une part et du sodium échange-
able (r 0,37; P K 0,005) ou du volume sanguin (r = 0,29;
P K 0,05) d'autre part. L'analyse des regressions multiples
prenant en compte Ia durée d'évolution de l'hypertension comme
deuxième variable indépendante augmente ces coefficients de
correlation qui deviennent respectivement 0,44 et 0,42. Ccci
suggère que l'hypertension de l'insuffisance rénale terminale est
souvent associée au réajustement du mécanisme de rétro-
contrOle sodium/volume-rénine. L'augmentation inadequate de
l'activité rénine plasmatique par rapport a Ia situation sodium/
volume de même que les modifications vasculaires induites par
l'augmentation de pression artérielle peuvent jouer des roles
complénientaires importants. Mais il apparait a l'évidence que
d'autres mécanismes sont aussi impliqués dans Ic maintien de
l'hypertension de l'insuffisance rénale terminale.
The body fluid volume and the functional activity
of the renin-angiotensin system are linked by a com-
plex feedback mechanism and they are normally in
equilibrium [1, 2]. Studies in laboratory animals and
normal man have suggested that fluid volume-renin
homeostasis may be an important factor in blood
pressure regulation [2, 3]. Present evidence indicates
that abnormalities in body sodium/water content or
renin metabolism participate in the pathogenesis of
several types of secondary hypertension [4-1 1]; some
authors have gone even further and proposed that
volume expansion or angiotensin vasoconstriction or
both may be the common basis of most categries of
human arterial hypertension, including essential
hypertension [10].
In hypertension associated with terminal renal fail-
ure, the frequent presence of sodium/fluid retention
and the occasional occurrence of markedly elevated
plasma renin concentrations have been well-docu-
mented [4-6, 8, 9, 12]. However, due to the paucity of
studies with simultaneous determinations of both the
sodium/volume state and circulating renin, the rela-
tive pathogenic importance of these two factors has
remained difficult to judge. Recently, patients with
end-stage renal hypertension were reported to have
abnormally high concentrations of plasma renin and
angiotensin II relative to body sodium [13]. The pres-
ent study was undertaken to further investigate the
interrelations between blood pressure, exchangeable
sodium, blood volume and plasma renin activity in a
large population of normal subjects and hemodialysis
patients with normal or elevated blood pressure.
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Studies were carried out in 31 normal volunteers,
and in 52 patients with terminal renal failure main-
tained by intermittent hemodialysis.
The normal subjects included 10 females and 21
males, ranging in age from 19 to 51 yr. Before the
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study no special attempt was made to control sodium
intake, except that these normal volunteers were in-
structed to either maintain their usual dietary habits
or to avoid adding salt to their food during at least
five days prior to the study.
The hemodialysis patients included 23 females and
29 males, ranging in age from 26 to 72 yr. The diag-
nosis of the renal disease, based on clinical signs and
laboratory tests or microscopic examination of the
kidneys, was pyelonephritis or interstitial nephritis of
other etiology in 23, glomerulonephritis in 18, poly-
cystic kidney disease in 8 and nephrosclerosis in 3 of
these nonnephrectomized patients. Total duration of
hemodialysis treatment ranged from 2 to 70 months.
All patients were dialyzed regularly two or three
times per week and they were instructed to restrict
their fluid intake and to follow a diet containing 1 to
1.5 g of sodium. The dialysate contained 132 mEq/
liter of sodium. All patients were clinically stable and
showed no signs of congestive heart failure, ascites
or edema.
At the time of this study, 23 of the 52 hemodialysis
patients had a mean blood pressure of less than 110
mm Hg and were considered normotensive. Twenty-
nine patients had a mean pressure which was equal to
or greater than 110 mm Hg and were considered to be
hypertensive; the hypertension was in the malignant
phase (hypertensive retinopathy Keith-Wagener grade
IV) in two of them.
In addition to stratifying the patients by their
blood pressure at the time of this study into those
having normal or elevated blood pressure, efforts
were undertaken to obtain all available information
regarding the long-term course of blood pressure.
Since the majority of these patients had primary renal
disease, blood pressure measurements were made reg-
ularly during follow-up visits; thus, the course of
blood pressure in these patients was generally well-
documented. Reports from referring physicians, in-
patient or outpatient hospital records or both, and
hemodialysis records were available in each patient.
In 49 patients hypertension was either detected simul-
taneously with the initial signs or symptoms of renal
disease or it developed under observation during the
course of progressive renal failure. The remaining
three patients had essential hypertension of several
years' known duration before renal function was
found to deterioriate. At the start of maintenance
hemodialysis, 44 of the 52 patients (85%) were hyper-
tensive. During the period of hemodialysis treatment,
blood pressure returned to normal values in more
than one-half of the initially hypertensive patients,
although transient episodes of hypertension recurred
in several of them. Known duration of hypertension
was defined as the estimated duration of elevated
blood pressure, beginning with the first objective re-
cording of an increase in blood pressure, and includ-
ing intermittent episodes of hypertension during
hemodialysis. In the 44 patients who developed hy-
pertension during the course of their illness, known
duration of blood pressure elevation ranged from
0.15 to 20 yr, with a mean of 3.6 yr.
Antihypertensive drug therapy was withdrawn at
least two weeks prior to the study, except in two
patients with very severe hypertension in whom the
drug-free interval had to be limited to one week.
Studies were always carried out during the 24-hr in-
terval before a regularly scheduled hemodialysis;
thus, the measurements which are specified below
were made two to three days after the last dialysis
treatment.
Total exchangeable sodium was measured by the
radioisotope dilution technique using 24Na [14]. A
dose of approximately 60 jCi of 24Na was ad-
ministered orally between 8 and 8:30 AM and urine
was collected during the subsequent 24 hr. During
this collection period, dietary conditions included a
sodium-restricted lunch (hemodialysis patients) or a
lunch without added salt (normal subjects), a light
salt-poor dinner and overnight fasting. During the
last hour of the 24-hr period, the subjects remained
in the supine position and blood samples were
obtained (a) five minutes before the end of this
period for triplicate determination of 23Na and
duplicate counting of 24Na activity in plasma, and
measurement of plasma renin activity and plasma
calcium and magnesium concentrations; and b) ten
minutes later for another series of triplicate deter-
minations of 23Na and duplicate counting of 24Na.
Twenty-four-hour exchangeable sodium (Nae) was
obtained by the following formula:
Nae (mEq) = 24Na dose — 24Na excreted
mean plasma concentration of 24Na
mean plasma concentration of 23Na.
Plasma volume in the supine position was deter-
mined immediately after the blood collections for
exchangeable sodium and renin. This was done by the
isotope dilution technique using 1311-human serum
albumin [14]; 1311 plasma concentration at time zero
was obtained by extrapolation of the values measured
10, 20 and 30 mm following injection in the normal
subjects and 10 and 20 mm following injection in the
hemodialysis patients. The radioactivity of peripheral
venous blood was used to calculate whole blood vol-
ume by assuming the following:
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Whole blood volume = measured volume X
100 — hematocrit
100 — 0.91 X hematocrit
Exchangeable sodium, and plasma and blood vol-
umes were expressed as mEq/kg of lean body mass
(LBM) and mi/kg of LBM, respectively. LBM was
estimated by using the leanness index of Nicholson
and Zilva [15]; this index is the ratio of body
height3/weight.
Plasma and urinary sodium (23Na) and potassium
concentrations were determined by flame photom-
etry (Instrumentation Laboratory), plasma calcium
and magnesium concentrations with an atomic
absorption spectrophotometer (Unicam SP 1900).
Plasma renin activity was measured in duplicate
samples by the radioimmunoassay method of Sealey,
Gerten-Banes and Laragh [16]; within assay varia-
tion in these duplicate samples averaged 4.1%
(N = 214) and between assay variation in our labora-
tory is 6.4% (N = 36). Blood pressure measurements
were obtained with a standard pressure cuff and
sphygmomanometer immediately before the blood
collections for exchangeable sodium and renin and
while the patients were supine and resting. The pres-
sure at the disappearance of the Korotkoff sounds
was taken to be diastolic blood pressure. Each blood
pressure recording was the mean of three readings.
Mean blood pressure was calculated as the sum of the
diastolic pressure and one-third of the pulse pressure.
Results
Blood pressure and pulse rate. Systolic, mean and
diastolic blood pressures averaged 118/91/78 mm Hg
in the normal control subjects, 13 1/99/82 mm Hg in
the hemodialysis patients with normal blood pressure
and 173/128/106 mm Hg in the hypertensive pa-
tients. Systolic and mean pressures in the normo-
tensive hemodialysis patients were significantly higher
than the values found in the normal control sub-
jects (P < 0.05).
Mean pulse rates were higher (P < 0.05) in normo-
tensive (79 9 beats/mm) or hypertensive (76 15
beats/mm) hemodialysis patients than in normal sub-
jects (67 + 10 beats/mm).
Exchangeable body sodium and blood volumes. In
the normal subjects, the relationship between ex-
changeable sodium and the leanness index of Nichol-
son and Zilva [15] was almost identical to that found
by these authors. Using this leanness index for esti-
mation of LBM, the normal subjects had a mean ex-
changeable body sodium of 51.1 + 3.9 mEq/kg of
LBM and a mean blood volume of 80.8 11.0 mi/kg
of LBM (Table 1). In the hemodialysis patients, ex-
changeable sodium correlated positively with blood
volume (r = 0.73; P < 0.001). The hypertensive pa-
tients showed significant (P < 0.005) increases in
both exchangeable sodium and blood volume (Table
1). In the patients with normal blood pressure, mean
exchangeable sodium was also elevated (P < 0.001);
blood volumes were more variable and did not differ
significantly from those in normal subjects. Com-
pared to the 95% confidence range obtained from
normal subjects, an increased exchangeable sodium
was found in eight of 23 (34%) hemodiaiysis patients
with normal blood pressures and in ten of 29 (34%)
hypertensive patients; blood volume values showed
also considerable overlap between the two groups.
Thus, although mean exchangeable sodium and
blood volumes were slightly higher in hypertensive
patients than in patients with normal blood pressure,
these differences were not significant.
Plasma renin activity. Mean plasma renin activity
in the normal subjects was 2.17 1.22 ng/mI/hr,
ranging from 0.58 to 5.6 ng/mi/hr; the values in
hemodialysis patients with normal blood pressure
were comparable. Mean plasma renin in the hy-
pertensive hemodialysis patients was 7.56 8.51
ng/ml/hr, which is significantly higher than the val-
ues in normal subjects or normotensive hemodialysis
patients (P < 0.005) (Table 1).
Correlation between the body sodium/volume state
and renin. Linear regression analysis showed signifi-











Normal subjects 31 51.1 + 3.9 80.8 I 1.0" 2.17 + 1.22
1-lernodialysis patients
HP," <110 mm Hg 23 57.8 73" 82.0 12.6 3.27 + 3.25
P,  110 mm Hg 29 60.9 + 10.4" 86.9 16.0" 7.56 8.51d
"Blood volume was measured in 30 normal subjects.
bBP = mean blood pressure.
"Significant difference vs. normal subjects (P < 0.001).
dsignifIcance difference vs. normal subjects and normotensive hemodialysis patients (P < 0.005).
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In the hypertensive hemodialysis patients, increases
in these products were more common, with an ele-
vated sodium-renin product in 19 of 29 patients
(66%) (Fig. 3) and an increased volume-renin product
in 10 of 29 cases (34%) (Fig. 4). The patients with
normal blood pressure and elevated sodium-renin
product and the hypertensive patients with a normal
sodium-renin product showed no significant differen-
ces in their mean plasma sodium (139.3 3.7 vs.
136.4 4.9 mEq/liter), potassium (5.3 0.9 vs. 5.3
0.9 mEq/liter), calcium (9.4 1.1 vs. 9.3 1.0
mg/lOO ml) or magnesium (3.2 0.3 vs. 3.0 0.8
mg/l00 ml) concentrations.
Relationship between blood pressure and various in-
dexes. Analyzing hemodialysis patients alone, mean
blood pressure correlated significantly with the so-
dium-renin product (r = 0.37; P < 0.01)(Fig. 5 A) or
the volume-renin product (r 0.29; P < 0.05), but
not with exchangeable sodium, blood volume or
plasma renin activity individually (Table 2). When
hemodialysis patients and normal subjects were
analyzed together, blood pressure correlated signifi-
cantly with either exchangeable sodium (r = 0.39;
P < 0.001) or plasma renin activity (r = 0.35;
P < 0.005), but correlation coefficients for the
relationships between blood pressure and the so-
dium-renin product (r = 0.55) or the volume-renin
cant inverse correlations between exchangeable so-
dium and plasma renin activity in normotensive (r =
—0.75; P < 0.0025) and hypertensive (r =—0.74; P <
0.001) hemodialysis patients (Fig. 1); and between
blood volume and renin activity in normotensive (r =
—0.47; P < 0.025) and hypertensive (r = —0.66; P <
0.005) hemodialysis patients as well as in normal
control subjects (r = —0.44; P < 0.01) (Fig. 2). In
addition, for any given exchangeable sodium or
blood volume, mean plasma renin activity was more
than two times higher in hypertensive than in normo-
tensive hemodialysis patients or normal subjects,
without consistent differences between the two latter
groups.
Sodium/volume-renin products. The "sodium-re-
nm" product was obtained by multiplying exchange-
able sodium (expressed as mEq/kg of LBM) with
the natural logarithm of plasma renin activity
(expressed as ng/liter/min to avoid negative loga-
rithms); the blood volume-renin product was derived
in a similar way. Most hemodialysis patients with a
normal blood pressure also showed normal sodium-
renin and volume-renin products; increases in the
sodium-renin product were found in only five of these
23 patients (21%) (Fig. 3) while the volume-renin
product was elevated in two of 22 cases (9%) (Fig. 4).
60 80 100 120


























Exchangeable sodium, rn//kg of LBM
r
—0.10 NS0 Normal subjects 31




Fig. 1. Relationship between exchangeable sodium and plasma renih

































Q..... Normal subjects 28 —0.44 0.01
liemodialysis patients2. BP < 110mm Hg 22 —0.47 0.025
L BP 110 mm Hg 29 —0.66 0.005
Fig. 2. Relationship between blood volume and plasma renin activity
in normal subjects and hemodialysis patients with normal or elevated
blood pressure.










Fig. 3. The sodium-renin product" in normal subjects and hemo-
dialysis patients with normal or elevated blood pressure.
product (r = 0.43) were again higher (Table 2).
These relationships were analyzed further by niul-
tiple regression analysis, using the natural logarithm
of the known duration of previous hypertension as
second independent variable. This latter factor was
calculated as in (1 + duration of hypertension [yr]),
so that in patients with normal blood pressure and
without previous hypertension it was zero. In the
hemodiàlysis patients, introduction of duration of
hypertension as second independent variable im-
proved the correlation coefficient for the pressure-
sodium-renin relationship from 0.37 to 0.44, while
the correlation coefficient for the pressure-volume-
renin relationship was increased from 0.29 to 0.42
(Table 2). To demonstrate the relationships in a two-
dimensional graph, the product of exchangeable so-
dium, renin and duration of hypertension was calcu-
lated and found to correlate equaliy well with blood
pressure (Fig. 5 B); use of blood volume instead of
exchangeable sodium revealed a similar result.
Discussion
The present finding of significant (P < 0.005) in-
creases in mean exchangeable body sodium, blood
volume and plasma renin activity in hypertensive
hemodialysis patients as compared to normal sub-
jects is consistent with previous studies, in which
these indexes were evaluated separately [4-6, 8, 9, 17-
19]. However, in our stable hemodialysis population
in which clinical signs of overhydration were absent,
increases in exchangeable sodium were equally corn-
mon (34%) in the 23 normotensive and the 29 hyper-
tensive patients. Furthermore, although blood vol-
umes and plasma renin concentrations tended to be
lower in normotensive than in hypertensive patients,
there was also a marked overlap of these values.
Thus, separate analysis of the hemodialysis patients
revealed no consistent interrelations between blood
pressure and body sodium or circulatory volume or
plasma renin individually, although correlations be-
tween blood pressure and exchangeable sodium or
renin activity became statistically significant when
normal subjects and dialysis patients were evaluated
together (r = 0.39 and 0.35, respectiely; P < 0.005).
Several other studies have also failed to demonstrate
close interrelations when blood pressure was corre-
lated with the body sodium/water state or circulating
renin concentrations individually [17, 20-22].
In this study, plasma renin activity was analyzed in
relation to exchangeable body sodium and blood vol-
ume. This approach revealed significant inverse cor-
relations between circulating renin and the sodium/
volume state in hemodialysis patients with either
normal or elevated blood pressure. Furthermore,
mean renin activity for a given exchangeable sodium
or blood volume was two times higher in the hyper-
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Fig. 4. The "volume-renin product" in normal subjects and hemo-
dialysis patients with normal or elevated blood pressure.





lation [28]. Our data indicate that in end-stage renal
hypertension there is frequently resetting rather than
complete failure of the physiological body
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these patients were analyzed as a group, circulating
renin was still in balance with the body sodium/
volume state, but this relationship was shifted to
the right.
The factors causing resetting of body fluid-renin
homeostasis are presently unclear. It is probable that
ischemic renal lesions may provide a stimulus for
.
inappropriate renin release at any state of hydration
[12, 29]. In addition, hypertensive hemodialysis
patients with high plasma renin activity were also





catecholamines [30], a factor which is known to have
renin-stimulatory potential [31, 32]. However,











function of the sympathetic system per se or through
the effects of high levels of circulating angiotensin II
[33, 34]. Therefore, elevated plasma catecholamines
in terminal renal failure could be either the cause or
the effect of inappropriate renin release.
Blood pressure effects of exogenous angiotensin II
correlate with the logarithm rather than with the
80 - . absolute dose [35—37], and they vary inversely with
body sodium balance [38, 39]. Therefore, Rosen and
I I
60 250 500 750 1000
Product of sodium, renin and duration of previous hypertension
B
Fig. 5. A, Relationship between blood pressure and the "sodium-renin
product" in normal subjects and hemodialysis patients. normal
subjects; •, hemodialysis patients. B, Relationship between blood
pressure and the product of exchangeable sodium, the logarithm of
renin activity and the logarithm of the duration of previous hyperten-
sion. •, hemodialysis patients.
pressure or normal subjects, but was comparable in
the latter two groups.
The demonstration of an abnormal body sodium-
renin relationship in hypertensive hemodialysis
patients is consistent with the findings of Davies et al
[13]. Aberrations in this relationship in hypertensive
as compared to normotensive hemodialysis patients
were also noted by others [21, 23]. The present find-
ing of generally comparable alterations in blood vol-
ume-renin interrelations provides a further link [24]
in a chain of events which may participate in the
pathogenesis of renal hypertension.
Renin responsiveness to acute changes in body
posture or hydration is often blunted in hemodialysis
patients [18, 25, 27, 29, 30]. However, in certain
hypertensive hemodialysis patients, chronic volume
depletion was found to cause progressive renin stimu-
Robinson have suggested estimating "effective" renin
by calculating the product of exchangeable sodium
and the logarithm of plasma renin concentration; in a
group of hemodialysis patients they noted a signifi-
cant relationship between blood pressure and "effec-
tive" renin [23]. The present findings support these
observations. Individually, exchangeable sodium,
blood volume or plasma renin activity did not corre-
late significantly with blood pressure when the 52
hemodialysis patients were analyzed separately; how-
ever, blood pressure correlated with the products of
plasma renin activity and exchangeable sodium (r =
0.37; P < 0.01) or blood volume (r = 0.29; P <0.05).
Combined analysis of hemodialysis patients and nor-
mal subjects showed a similar tendency, with higher
correlation coefficients between blood pressure and
the sodiurn-renin (r = 0.55) or volume-renin (r =
0.43) products, than between pressure and exchange-
able sodium (r = 0.39) or blood volume (r = 0.12)
individually. These data support the concept of
complementary pathogenic roles of the body so-
dium/volume state and circulating renin in hyperten-
sion accompanying terminal renal failure.
Nevertheless, certain hemodialysis patients with
normal blood pressure had increased plasma renin
concentrations relative to the body sodium/volume
state, while some patients 'with severe or even malig-
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Table 2. Correlations between mean blood pressure and the sodium/volume state and/or plasma renin concentrations and
duration of previous hypertension
Hemodialysis patients
Hemodialysis patients and normal subjects
N r P N r P
Mean blood pressure vs.
Nae° 52 0.14 NS 83 0.39 <0.001
BVb 51 0.06 NS 79 0.12 NS
In PRAC 52 0.26 NS 83 0.35 <0.005
Nae X In PRA 52 0.37 <0.005 83 0.55 <0.001
Na, X In PRA lfltBEI 52 0.44 <0.OQI
BY X In PRA 51 0.29 <0.05 79 0.43 <0.001
BV X In PRA and lntBpI 51 0.42 <0.005
'Nae = exchangeable sodium, bBV = blood volume, 'ln PRA = natural logarithm of plasma renin activity, dlntapt = natural logarithm of
known duration of hypertension.
nant hypertension had normal sodium/volume-renin
products. This considerable variation in blood pres-
sure-sodium/volume-renin interrelations indicates
that additional important mechanisms must be in-
volved, either by altering hemodynamic functions
directly or by modulating vascular reactivity to so-
dium, angiotensin or other pressor factors. A recent
report of increased noradrenalin sensitivity in
patients with high plasma renin concentrations is
consistent with the latter possibility [40]. In addition,
vascular reactivity could be altered as a result of
abnormalities in plasma electrolyte composition [41].
However, variations in blood pressure-sodium/
volume-renin interrelations in our patients could
not be explained by changes in plasma concentra-
tions of sodium, potassium, magnesium or calcium.
Multiple regression analysis introducing the loga-
rithm of the known duration of previous hyperten-
sion as second independent variable consistently
resulted in slight increases of the correlation coeffi-
cients for the
-
relationships between blood pres-
sure and the sodium-renin or volume-renin products.
This suggests that certain changes resulting from pre-
vious hypertension may influence blood pressure
regulation in hemodialysis patients. The exact mean-
ing of this factor is presently unclear. However, it has
been suggested that the maintenance of experimental
and human hypertension may be related partly to
high blood pressure-induced hypertrophic changes of
the resistance vessels [42, 43], and it would appear
reasonable to assume that the severity and extent of
such vascular alterations increase with duration of
hypertension.
Therefore, our data are consistent with the concept
that resetting of the body sodium/volume-renin feed-
back mechanism due to renal damage and vascular
alterations accompanying chronic blood pressure ele-
vation may both be important factors in the mainte-
nance of end-stage renal hypertension. However, it is
also evident that blood pressure control in these
patients is very complex and that further important
mechanisms including altered vascular reactivity should
be considered in order to unveil the "mosaic" of
renal hypertension more completely.
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